TCMBANKIN002539 |
pelargonidin |
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1lambda-chromen-1-ylium; Pelargonidin-3,5-diglucoside_qt; 7690-51-9; C05904; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromenylium; XVFMGWDSJLBXDZ-UHFFFAOYSA-O; 3,4',5,7-Tetrahydroxyflavylium; anthocyanidin; pelargonidin 3,5-di-O-glycoside_qt; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-1-benzopyrylium; CHEBI:25863; 2-(4-hydroxyphenyl)chromenylium-3,5,7-triol; 2-(4-hydroxyphenyl)-1-benzopyrylium-3,5,7-triol; LMPK12010003; CHEMBL591036; pelargonidin-3-O-glucoside_qt; pelargonidin-3,5-di-O-glucoside_qt; BDBM50121994; CHEMBL1197905; A806724; BDBM50326998; 1-Benzopyrylium, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-; SCHEMBL20592; 134-04-3 (chloride); ZINC391840; Pelargonidin; AC1L9A0P; ZB012073 |
C15H11O5+ |
271.24 g/mol |
C1=CC(=CC=C1C2=[O+]C3=CC(=CC(=C3C=C2O)O)O)O |
TCMBANKIN006996 |
Ziebeimine |
ziebeimine |
C27H43NO2 |
413.64 |
CC1CCC2C(C3=C(CN2C1)C4CC5C(C4CC3)CC(C6C5(CCC(C6)O)C)O)C |
TCMBANKIN007862 |
peumine |
|
|
|
|
TCMBANKIN009757 |
trans-communicacid methyl ester |
|
C21H32O2 |
|
CC(=CCC1C(=C)CCC2C1(CCCC2(C)C(=O)OC)C)C=C |
TCMBANKIN018528 |
hapepunine 3-o-α-l-rhamnosyl-(1→2)-β-d-glucopyranoside |
|
C40H67NO11 |
|
|
TCMBANKIN020120 |
Peiminoside |
peiminoside |
C33H55NO7 |
577.8 g/mol |
CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(C6C5(CCC(C6)OC7C(C(C(C(O7)C)O)O)O)C)O)(C)O |
TCMBANKIN022945 |
peiminine |
Peiminine; Raddeamine; Imperialine; Sipeimine; Fritillarine; zhebeinine |
C27H43NO3 |
429.6 g/mol |
CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(=O)C6C5(CCC(C6)O)C)(C)O |
TCMBANKIN023799 |
solanidine-3-o-α-l-rhamnopyranosyl-(1→2)-β-d-glucopyranosyl-(1→4)-β-d-glucopyrano-side |
|
|
|
|
TCMBANKIN025202 |
Chaksine |
486-53-3; (3R,7R,11R,15R)-3,11-bis[(4R)-2-amino-4,5-dihydro-3H-imidazol-4-yl]-7,15-dimethyl-1,9-dioxacyclohexadecane-2,10-dione; C09940; 1,9-Dioxacyclohexadecane-2,10-dione, 3,11-bis(2-amino-4,5-dihydro-1H-imidazol-4-yl)-7,15-dimethyl-, (3R-(3R*(R*),7R*,11R*(R*),15R*))-; chaksine; (3R,7R,11R,15R)-3,11-bis[(4R)-2-amino-4,5-dihydro-3H-imidazol-4-yl]-7,15-dimethyl-1,9-dioxacyclohexadecane-2,10-quinone |
C22H38N6O4 |
450.57 |
CC1CCCC(C(=O)OCC(CCCC(C(=O)OC1)C2CNC(=N2)N)C)C3CNC(=N3)N |
TCMBANKIN025398 |
OSI-2040 |
NCGC00165733-01; (3S,6S,9S,12R)-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-3-sec-butyl-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone; (3S,6S,9S,12R)-3-[(2S)-butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone; (3S,6S,9S,12R)-9-(6-ketooctyl)-6-[(1-methoxyindol-3-yl)methyl]-3-sec-butyl-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-diquinone; (3S,6S,9S,12R)-6-[(1-methoxy-3-indolyl)methyl]-9-(6-oxooctyl)-3-sec-butyl-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone |
C34H49N5O6 |
623.78 |
CCC(C)C1C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)N1)CC3=CN(C4=CC=CC=C43)OC)CCCCCC(=O)CC |
TCMBANKIN026871 |
apicidin |
cyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl) |
C34H49N5O6 |
623.8 g/mol |
CCC(C)C1C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)N1)CC3=CN(C4=CC=CC=C43)OC)CCCCCC(=O)CC |
TCMBANKIN031414 |
Peiminoside_qt |
|
|
431.73 |
|
TCMBANKIN031607 |
Pelargonidin-3,5-diglucoside |
pelargonidin-3,5-diglucoside |
C27H31ClO15 |
631 g/mol |
C1=CC(=CC=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O.[Cl-] |
TCMBANKIN036983 |
trans-communol |
|
C20H32O |
|
CC(=CCC1C(=C)CCC2C1(CCCC2(C)CO)C)C=C |
TCMBANKIN037830 |
Picropodophyllin |
(10R,11S,16R)-16-hydroxy-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0;{3,7}.0;{11,15}]hexadeca-1,3(7),8-trien-12-one; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-alpha,8a-alpha,9-alpha))-; WLN: T E5 C665 FVO NO PO OHTT&&J DR CO1 DO1 EO1& JQ; Picropodophyllin; KBioGR_002538; 5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, [5R-(.alpha.-5a.alpha.,8a.alpha.,9.alpha.)]; Insulin-like Growth Factor-1 Receptor Inhibitor; SPECTRUM1504410; KBioSS_002116; BRN 0099161; NSC 36407; SCHEMBL13661743; Spectrum4_001836; IGF-1R Inhibitor, PPP; Spectrum3_001671; KBio2_004684; Lignans; (5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofurano[5,6-f][1,3]benzodioxol-8-one; KBio2_007252; C10871; SDCCGMLS-0066757.P001; Spectrum2_000520; AIDS006792; KBio3_002701; SPBio_000479; Picropodophyllotoxin; CCG-203057; AIDS-006792; KBio2_002116; 17434-18-3; Spectrum5_000631; Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.alpha.,8a.alpha.,9.alpha.)]-; Picropodophyllin (8CI); Spectrum_001636; 477-47-4; BSPBio_003481; (5R,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one; NCGC00161923-01; AC1L9DV2; NSC36407 |
|
414.41 |
|
TCMBANKIN038909 |
verticinone |
MolPort-006-823-865; Cevan-6-one, 3,20-dihydroxy-, (3beta,5alpha)-; CS-3732; AC1L50EW; 3beta,20-Dihydroxy-5alpha-cevan-6-one; UNII-QUB07U6VTQ; ZINC30727228; C10808; 059P104; Kashmirine; Fritillarine;; Fritillarine; CHEBI:5886; CCG-208360; C-22230; C27H43NO3; AKOS015895686; Verticinone;; Kashmirine;; Q-100214; AC1Q6P7C; QUB07U6VTQ; MFCD00210542; Zhebeinone; Peiminine; AC-7988; 1361-22-4; SCHEMBL5956998; ST51051241; 18059-10-4; 1357-77-3; 1357-21-7; HY-N0213; 1416-43-9; X1200 |
C27H43NO3 |
429.64 |
CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(=O)C6C5(CCC(C6)O)C)(C)O |
TCMBANKIN039153 |
Ebeiensine |
3-hydroxy-3',6',10,11b-tetramethylspiro[1,2,3,4,4a,6,6a,6b,7,8,11,11a-dodecahydrobenzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-5-one; AC1NSZH8 |
|
427.6 g/mol |
|
TCMBANKIN040541 |
Ebeinone |
|
|
411.6 g/mol |
|
TCMBANKIN040689 |
ent-Kaur-15-en-17-ol |
Kaur-15-en-17-ol; Ent-kaur-15-en-17-ol; 14696-33-4 |
|
288.47 |
|
TCMBANKIN041404 |
isobaimonidine |
|
C27H45NO3 |
|
|
TCMBANKIN041435 |
ent-Kauran-16β,17-diol |
|
|
|
|
TCMBANKIN041581 |
ent-16α-Methoxy-kauran-17-ol |
ent-16alpha-methoxy-kauran-17-ol |
|
|
|
TCMBANKIN042548 |
ent-Kauran-16α,17-diol |
|
|
|
|
TCMBANKIN042997 |
fritillarizine |
STOCK1N-49967; AKOS030501866; 76733-86-3; ZINC70688102; BG01702139; MCULE-6057699517; (1R,2S,6S,9S,10S,11S,14S,15S,20R,23R,24S)-6,10,23-TRIMETHYL-4-AZAHEXACYCLO[12.11.0.0(2),(1)(1).0?,?.0(1)?,(2)?.0(1)?,(2)(3)]PENTACOS-17-ENE-10,20-DIOL; MolPort-002-524-349 |
C27H43NO2 |
413.6 g/mol |
CC1CCC2C(C3CCC4C5CC=C6CC(CCC6(C5CC4C3CN2C1)C)O)(C)O |
TCMBANKIN043095 |
Zhebeininoside |
|
|
|
|
TCMBANKIN043389 |
verticinone-n-oxide |
|
|
|
|
TCMBANKIN045336 |
Hapepunine |
AC1O3DF4; 68422-01-5; (3S,8S,9S,10R,13S,14S,16S)-17-[(1S)-1-(1,5-dimethylpiperidin-2-yl)ethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16-diol |
|
429.7 g/mol |
|
TCMBANKIN045520 |
solanidine-3-o-α-l-rhamnopyranosyl-(1→2)-β-d-glucopyranoside |
|
|
|
|
TCMBANKIN046426 |
baimonidine |
|
C27H45NO3 |
|
|
TCMBANKIN046779 |
ent-17-norkauran-16-one |
|
C19H30O |
274.44 |
CC1(CCCC2(C1CCC34C2CCC(C3)C(=O)C4)C)C |
TCMBANKIN049013 |
ent-(16S)-atisan-13,17-oxide |
ent-(16s)-atisan-13,17-oxide |
C20H32O |
288.47 |
CC1(CCCC2(C1CCC34C2CC5C(C3)COC5C4)C)C |
TCMBANKIN058450 |
ADO |
nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside |
C10H13N5O4 |
267.24 g/mol |
C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
TCMBANKIN059668 |
16, 17-epoxykaurane |
|
C20H32O |
288.47 |
CC1(CCCC2(C1CCC34C2CCC(C3)C5(C4)CO5)C)C |
TCMBANKIN060039 |
THM |
|
C10H14N2O5 |
242.23 g/mol |
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O |
TCMBANKIN060044 |
5-methyluracil |
|
C5H6N2O2 |
126.11 g/mol |
CC1=CNC(=O)NC1=O |
TCMBANKIN060385 |
(16r)-ent-7β-hydroxykauran-15-one |
|
C20H32O2 |
|
CC1C2CCC3C4(CCCC(C4CC(C3(C2)C1=O)O)(C)C)C |
TCMBANKIN060428 |
Peimisine |
|
C27H41NO3 |
427.6 g/mol |
CC1CC2C(C(C3(O2)CCC4C5CC(=O)C6CC(CCC6(C5CC4=C3C)C)O)C)NC1 |
TCMBANKIN060578 |
Solanidine |
|
C27H43NO |
397.6 g/mol |
CC1CCC2C(C3C(N2C1)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C |
TCMBANKIN060582 |
Verticine |
|
C27H45NO3 |
431.7 g/mol |
CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(C6C5(CCC(C6)O)C)O)(C)O |
TCMBANKIN061761 |
Zhebeiresinol |
zhebeiresinol;caruilignan d |
C14H16O6 |
280.27 |
COC1=CC(=CC(=C1O)OC)C2C3COC(=O)C3CO2 |
TCMBANKIN061762 |
syringaresinol |
(+)-Suyringaresinol-di-O-beta-D-glucoside_qt; (+)syringaresinol; (+)-Suyringaresinol-di-O-beta-D-glucoside; liriodendrin_qt; dl-Syringaresinol; syringaresinol diglucoside_qt; dl-sy-ringaresinol; (+)-syringaresinol-O-β-D-glucopyranoside; (+ )-syringaresinol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 21453-69-0; C10889; (7alpha,7'alpha,8alpha,8'alpha)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol; CHEBI:47; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (+)-syringaresinol; (+ )- syringaresinol; dl-syringaresinol; (-)-syringaresinol; episyringaresinol; (+)-syringarosinol; (+ )-Syringaresinol-O-β-D-glucopyranoside; syringaresino; (-)-syringaresinol; (?)-syringaresinol; (+)-Syringaresinol; lirioresinol-A |
C34H46O18 |
742.72 |
COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC |